López MR, Suarez MC. Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: “Short-term emicizumab in patients with acquired hemophilia A”. Haematologica; https://doi.org/10.3324/haematol.2026.301818 [Early view].